LONDON : A trial to see whether two anti-malarial drugs -- chloroquine, hydroxychloroquine -- could prevent the novel coronavirus has begun in the UK's Brighton and Oxford.
The first UK participants in the global trial are being enrolled on Thursday at the Brighton and Sussex University Hospitals and the John Radcliffe Hospital in Oxford, reports the BBC.
They will be given either hydroxychloroquine or a placebo for three months. These are the first of a planned 25 UK sites, with results expected by the end of the year.
The trial is open to anyone delivering direct care to coronavirus patients in the UK, as long as they have not been diagnosed with COVID-19.